Last reviewed · How we verify
Zofran 8 mg
Zofran 8 mg is a Small molecule drug developed by Medical University of Gdansk. It is currently FDA-approved.
Zofran 8 mg is a small molecule medication used to treat conditions such as dehydration, gastroenteritis, vomiting, diarrhea, and post-operative nausea and vomiting. It is administered as a treatment in emergency departments, particularly for children with gastroenteritis and vomiting.
At a glance
| Generic name | Zofran 8 mg |
|---|---|
| Sponsor | Medical University of Gdansk |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Dexamethasone vs Ondansetron After Cesarean Delivery (PHASE4)
- Evaluation of Postoperative Pain Control in Ear Surgery (NA)
- E7 TCR T Cells for Human Papillomavirus-Associated Cancers (PHASE1, PHASE2)
- Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients (PHASE2)
- 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma (PHASE2)
- Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches (PHASE3)
- Ondansetron for the Management of Atrial Fibrillation (PHASE4)
- Post Operative Shivering Following Anesthesia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Zofran 8 mg CI brief — competitive landscape report
- Zofran 8 mg updates RSS · CI watch RSS
- Medical University of Gdansk portfolio CI
Frequently asked questions about Zofran 8 mg
What is Zofran 8 mg?
Who makes Zofran 8 mg?
What development phase is Zofran 8 mg in?
Related
- Manufacturer: Medical University of Gdansk — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing